AU3687500A - New combination of r,r-formoterol and budesonide in a pharmaceutical compositionuseful for treating respiratory disorders, such as asthma, rhinitis and copd - Google Patents
New combination of r,r-formoterol and budesonide in a pharmaceutical compositionuseful for treating respiratory disorders, such as asthma, rhinitis and copdInfo
- Publication number
- AU3687500A AU3687500A AU36875/00A AU3687500A AU3687500A AU 3687500 A AU3687500 A AU 3687500A AU 36875/00 A AU36875/00 A AU 36875/00A AU 3687500 A AU3687500 A AU 3687500A AU 3687500 A AU3687500 A AU 3687500A
- Authority
- AU
- Australia
- Prior art keywords
- compositionuseful
- formoterol
- budesonide
- copd
- rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9900834 | 1999-03-09 | ||
SE9900834A SE9900834D0 (en) | 1999-03-09 | 1999-03-09 | Novel combination |
PCT/SE2000/000418 WO2000053188A1 (en) | 1999-03-09 | 2000-03-02 | New combination of r,r-formoterol and budesonide in a pharmaceutical composition useful for treating respiratory disorders, such as asthma, rhinitis and copd |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3687500A true AU3687500A (en) | 2000-09-28 |
Family
ID=20414767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36875/00A Abandoned AU3687500A (en) | 1999-03-09 | 2000-03-02 | New combination of r,r-formoterol and budesonide in a pharmaceutical compositionuseful for treating respiratory disorders, such as asthma, rhinitis and copd |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3687500A (en) |
SE (1) | SE9900834D0 (en) |
WO (1) | WO2000053188A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
SE9703407D0 (en) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (en) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
SE0200312D0 (en) | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
SE0203376D0 (en) * | 2002-11-15 | 2002-11-15 | Astrazeneca Ab | New process |
MX2009008794A (en) | 2007-02-19 | 2009-08-25 | Cipla Ltd | Pharmaceutical combinations. |
CA2805700A1 (en) * | 2010-07-16 | 2012-01-19 | Cipla Limited | Pharmaceutical compositions comprising r(+) budesonide and formoterol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9603669D0 (en) * | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
-
1999
- 1999-03-09 SE SE9900834A patent/SE9900834D0/en unknown
-
2000
- 2000-03-02 WO PCT/SE2000/000418 patent/WO2000053188A1/en active Application Filing
- 2000-03-02 AU AU36875/00A patent/AU3687500A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SE9900834D0 (en) | 1999-03-09 |
WO2000053188A1 (en) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1462100E (en) | Composition comprising formoterol and a glucocorticosteroid | |
HUP0200142A2 (en) | Combinations of formoterol and mometasone furoate for asthma | |
MY126768A (en) | Combinations of formoterol and fluticasone propionate for asthma | |
AU3687400A (en) | New combination of formoterol and mometasone in a pharmaceutical composition fortreating respiratory disorders, such as asthma, rhinitis and copd | |
AU2003206311A1 (en) | Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases | |
AU2003206310A1 (en) | Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases | |
AU2009201956A2 (en) | Pregnane steroids for use in the treatment of CNS disorders | |
HUP0401514A3 (en) | Pharmaceutical compositions for the treatment of asthma | |
EE200000740A (en) | Use of a pharmaceutical composition containing formoterol and budesonide for the prevention or treatment of acute asthma conditions | |
ZA200208710B (en) | Novel process. | |
AU3687500A (en) | New combination of r,r-formoterol and budesonide in a pharmaceutical compositionuseful for treating respiratory disorders, such as asthma, rhinitis and copd | |
HUP0200613A2 (en) | Compounds and methods for treatment of asthma, allergy and inflammatory disorders, pharmaceutical compositions containing them and their use | |
AUPS017702A0 (en) | Methods and compositions for the treatment of asthma and related disorders | |
PL358375A1 (en) | Medicaments for treating respiratory disorders comprising formoterol and fluticasone | |
MXPA05001573A (en) | Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd. | |
AU2003260748A1 (en) | Il-14 vaccine for the treatment of asthma and atopic disorders | |
AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
SI1216047T1 (en) | Combination of loteprednol and beta2-adrenoceptor agonists and its use by inhalation for the treatment of bronchial asthma | |
AU2001243453A1 (en) | Herbal remedies for treating allergies and asthma | |
AU3071899A (en) | Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma | |
HK1070900A1 (en) | Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds | |
AU2002246307A1 (en) | Polyherbal composition for the treatment of bronchial asthma and the process | |
AU5916900A (en) | Method for treatment of asthma syndrome | |
HU9802379D0 (en) | Inhaler for treatment of asthma | |
AU2002325687A1 (en) | Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |